Citadel Advisors’s EMULEX CORP ELX Stock Holding History

Citadel Advisors’s Portfolio ELX Stock Details ELX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-19,000	Closed	-$151K	–	9461
2015 Q1	$151K	Sell	19,000 -9,400	-33%	-$65.9K	﹤0.01%	6473
2014 Q4	$161K	Buy	28,400 +17,900	+170%	+$96.5K	﹤0.01%	6223
2014 Q3	$52K	Buy	10,500 +3,000	+40%	+$16.2K	﹤0.01%	6886
2014 Q2	$43K	Buy	7,500 +3,900	+108%	+$23.2K	﹤0.01%	6869
2014 Q1	$27K	Sell	3,600 -18,700	-84%	-$137K	﹤0.01%	7156
2013 Q4	$160K	Buy	22,300 +3,600	+19%	+$26.7K	﹤0.01%	5238
2013 Q3	$145K	Buy	18,700 +3,800	+26%	+$29.5K	﹤0.01%	5046
2013 Q2	$97K	Buy	+14,900	New	+$93.7K	﹤0.01%	5252

Citadel Advisors's ELX Position: Q2 2015 in Review

Citadel Advisors sold out of EMULEX CORP (ELX) in Q2 2015, closing a stake of 20,188 shares — an estimated $161K sold.

Citadel Advisors first reported a position in ELX in Q2 2013 and held it in 8 quarters. The position peaked at $2.44M in Q1 2014. 0 funds tracked by Wall St. Rank hold ELX as of Q2 2015.

Citadel Advisors reported no remaining EMULEX CORP position as of Q2 2015 after selling out during the quarter.
Citadel Advisors sold 20,188 EMULEX CORP shares in Q2 2015, an estimated $161K.
Citadel Advisors first reported a position in EMULEX CORP in Q2 2013 and held it in 8 quarters.
Citadel Advisors's EMULEX CORP position peaked at $2.44M in Q1 2014.
0 funds tracked by Wall St. Rank held EMULEX CORP as of Q2 2015.

Based on Citadel Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.